Published in Arch Intern Med on August 01, 1992
Novel antithrombotic therapy. West J Med (1993) 1.39
Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood (2011) 1.14
Anticoagulation therapy in patients with venous thromboembolic disease. J Gen Intern Med (1998) 0.85
Standardization of clinical decision making for the conduct of credible clinical research in complicated medical environments. Proc AMIA Annu Fall Symp (1996) 0.82
Dosing of unfractionated heparin in obese patients with venous thromboembolism. J Gen Intern Med (2010) 0.80
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis (2016) 0.77
Heparin therapy for venous thromboembolism. West J Med (1994) 0.75
Heparin anticoagulation responsiveness in a coronary care unit: a prospective observational study. Cardiovasc Ther (2009) 0.75
Comparison of heparin dosing based on actual body weight in non-obese, obese and morbidly obese critically ill patients. Int J Crit Illn Inj Sci (2013) 0.75
Heparin should be administered to every patient admitted to the hospital with possible unstable angina. West J Med (2000) 0.75
The Role of Pharmacomechanical Endovascular Intervention for Iliofemoral Vein Thrombosis Compared to Conventional Anticoagulation Therapy. J Korean Med Sci (2017) 0.75
Stages of change and decisional balance for 12 problem behaviors. Health Psychol (1994) 9.28
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 7.31
Prevention of venous thromboembolism. Chest (2001) 5.59
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med (1998) 3.70
A clinician's guide for conducting randomized trials in individual patients. CMAJ (1988) 3.35
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med (1992) 3.23
Declining sex ratios in Canada. CMAJ (1997) 3.02
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89
Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med (2000) 2.82
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med (1993) 2.76
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet (2000) 2.74
Chronic idiopathic thrombocytopenic purpura. N Engl J Med (1994) 2.66
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA (2001) 2.49
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
A population-based, randomized clinical trial on back pain management. Spine (Phila Pa 1976) (1997) 2.30
Cost-effectiveness of pulmonary embolism diagnosis. Arch Intern Med (1996) 2.24
Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med (1992) 2.23
Low-probability lung scan findings: a need for change. Ann Intern Med (1991) 2.22
Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med (2000) 2.12
Real-world variability in dabigatran levels in patients with atrial fibrillation. J Thromb Haemost (2015) 2.07
Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA (2001) 2.05
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study. J Thromb Haemost (2014) 2.03
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med (1998) 2.03
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med (1994) 1.97
Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing. Ann Intern Med (2001) 1.93
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest (1985) 1.92
Does this patient have deep vein thrombosis? JAMA (1998) 1.90
A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation (1995) 1.90
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.80
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch Intern Med (2000) 1.72
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med (2000) 1.70
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med (2001) 1.70
Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med (2001) 1.68
Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost (2008) 1.67
Treatment of acute colonic pseudoobstruction (Ogilvie's syndrome) with cisapride. Gastroenterology (1990) 1.67
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA (1998) 1.67
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. Chest (1990) 1.65
Mortality and institutionalization following hip fracture. J Am Geriatr Soc (2000) 1.65
A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost (2006) 1.59
The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med (1998) 1.58
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost (2001) 1.58
The impact of re-engineering and other cost reduction strategies on the staff of a large teaching hospital: a longitudinal study. Med Care (1999) 1.57
Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. Arch Intern Med (1994) 1.56
Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood (1992) 1.55
Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis (2001) 1.55
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA (1990) 1.55
Coronary artery bypass grafting in Canada: national and provincial mortality trends, 1992-1995. CMAJ (1998) 1.53
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. Arch Intern Med (1997) 1.53
Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood (1993) 1.52
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med (1983) 1.51
Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea. Thorax (2000) 1.51
Choroid plexus tumours. Br J Cancer (2002) 1.50
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med (1999) 1.50
Clinical importance of pharmacist-obtained medication histories using a validated questionnaire. Am J Hosp Pharm (1984) 1.50
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.48
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med (1996) 1.45
Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb Haemost (1991) 1.45
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med (1994) 1.44
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests. Am J Med (2000) 1.40
Prevalence of gastroesophageal reflux symptoms in asthma. Chest (1996) 1.40
Cost-benefit and cost-effectiveness analysis of a disability prevention model for back pain management: a six year follow up study. Occup Environ Med (2002) 1.37
Coronary artery bypass grafting in Canada: hospital mortality rates, 1992-1995. CMAJ (1998) 1.35
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.34
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. Arch Intern Med (1997) 1.34
Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31
The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med (1973) 1.30
Implementation of a participatory ergonomics program in the rehabilitation of workers suffering from subacute back pain. Appl Ergon (2001) 1.30
Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet (1992) 1.29